Unlocking Insights: Wearables & Data for Sickle Cell Crisis Prediction

Predicting Vaso-Occlusive Crises in Sickle Cell Disease through Digital, Longitudinal Tracking of Wearable Metrics and Patient-Reported Outcomes

American Society of Haematology Exposition
(2023) — Oral Presentation

Wearable Technology To Support Asthma Patients And Improve NHS Capacity

Collaboration with Modality Partnership
(2023 )

Disparate Prediction of Outcomes in A Uniformly Treated Cohort of Patients with AL Amyloidosis Stratified by Mayo 2012 & European Cardiac Staging Systems

European Haematology Association
(2023)

A Real-World digital monitoring Study exploring the Day-to-Day Experience of Patient activity, Sleep, and outcome measures in WM

University College London Hospital NHS Trust
(2023 )

Understanding the Experiences of Patients with Sickle Cell Disease and Their Caregivers By Social Media Listening in the UK

Collaboration with Pfizer Ltd., American Society of Haematology Exposition
(2023)

Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease

Collaboration with Pfizer Ltd., American Society of Haematology Exposition
(2023)

Real-World Outcomes and Digitally Monitored Quality of Life in Crizanlizumab-Treated Patients With Sickle Cell Disease

European Haematology Association
(2023)

Using Wearables and Web-Based Self-Reporting to Explore Deep Sleep and PRO correlations in Sickle Cell Disease

63rd Annual Meeting, British Society of Haematology
(2023)

Real-World PROs and Wearable Metric Correlations: Remote Daily Monitoring for Exploration of Quality of Life in Sickle Cell Disease

17th Annual Sickle Cell and Thalassaemia Conference
(2022)

Live Outcomes and Biometric Monitoring: Potential Implications For Patient Quality of Life in Sickle Cell Disease

17th Annual Sickle Cell and Thalassaemia Conference
(2022)

Real-Time Vaccination Impacts in Sickle Cell Disease: A Real-World Patient Case Study for Influenza and Covid-19 Vaccination

Annual Academy of Sickle Cell and Thalassaemia Conference, ASCAT
(2022)